Literature DB >> 27306389

Imaging in Advanced Non-Small Cell Lung Cancer: A Medical Oncology Perspective.

Anastasios Dimou1, Carol Sherman, John Wrangle.   

Abstract

Treatment advances have improved outcomes in patients with lung cancer, with a number of targeted therapies and immunotherapies now approved for patients with metastatic disease. Along with longer survival, modern treatment paradigms have increased therapeutic decision-making complexity underscoring informative imaging as paramount in guiding clinical care. In this review, we summarize challenges the thoracic oncologist encounters in common clinical settings. In addition, we explore unmet needs for future investigations with particular focus on positron emission tomography technology and immunotherapies.

Entities:  

Mesh：

Year:  2016        PMID： 27306389      PMCID： PMC6461391          DOI： 10.1097/RTI.0000000000000219

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN： 0883-5993            Impact factor:   3.000


  46 in total

Review 1.  Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development.

Authors:  Gary J Kelloff; John M Hoffman; Bruce Johnson; Howard I Scher; Barry A Siegel; Edward Y Cheng; Bruce D Cheson; Joyce O'shaughnessy; Kathryn Z Guyton; David A Mankoff; Lalitha Shankar; Steven M Larson; Caroline C Sigman; Richard L Schilsky; Daniel C Sullivan
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

2.  Staging non-small cell lung cancer with whole-body PET.

Authors:  E M Marom; H P McAdams; J J Erasmus; P C Goodman; D K Culhane; R E Coleman; J E Herndon; E F Patz
Journal:  Radiology       Date:  1999-09       Impact factor: 11.105

3.  Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes.

Authors:  T Le Chevalier; G Scagliotti; R Natale; S Danson; R Rosell; R Stahel; P Thomas; R M Rudd; J Vansteenkiste; N Thatcher; C Manegold; J-L Pujol; N van Zandwijk; C Gridelli; J P van Meerbeeck; L Crino; A Brown; P Fitzgerald; M Aristides; J H Schiller
Journal:  Lung Cancer       Date:  2005-01       Impact factor: 5.705

Review 4.  Positron emission tomography for target volume definition in the treatment of non-small cell lung cancer.

Authors:  Konstantin Lavrenkov; Mike Partridge; Gary Cook; Michael Brada
Journal:  Radiother Oncol       Date:  2005-10-12       Impact factor: 6.280

Review 5.  Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis.

Authors:  Yo Won Choi; Reginald F Munden; Jeremy J Erasmus; Kyung Joo Park; Woo Kyung Chung; Seok Chol Jeon; Choong-Ki Park
Journal:  Radiographics       Date:  2004 Jul-Aug       Impact factor: 5.333

6.  EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.

Authors:  William Pao; Vincent Miller; Maureen Zakowski; Jennifer Doherty; Katerina Politi; Inderpal Sarkaria; Bhuvanesh Singh; Robert Heelan; Valerie Rusch; Lucinda Fulton; Elaine Mardis; Doris Kupfer; Richard Wilson; Mark Kris; Harold Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

7.  Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use.

Authors:  Wolfgang A Weber; Volker Petersen; Burkhard Schmidt; Leishia Tyndale-Hines; Thomas Link; Christian Peschel; Markus Schwaiger
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

8.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Authors:  Thomas J Lynch; Daphne W Bell; Raffaella Sordella; Sarada Gurubhagavatula; Ross A Okimoto; Brian W Brannigan; Patricia L Harris; Sara M Haserlat; Jeffrey G Supko; Frank G Haluska; David N Louis; David C Christiani; Jeff Settleman; Daniel A Haber
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

9.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

10.  Development of new mouse lung tumor models expressing EGFR T790M mutants associated with clinical resistance to kinase inhibitors.

Authors:  Lucia Regales; Marissa N Balak; Yixuan Gong; Katerina Politi; Ayana Sawai; Carl Le; Jason A Koutcher; David B Solit; Neal Rosen; Maureen F Zakowski; William Pao
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240
View more
  1 in total

1.  Imaging CAR T-cell kinetics in solid tumors: Translational implications.

Authors:  Matthew S Skovgard; Hocine R Hocine; Jasmeen K Saini; Maxim Moroz; Rebecca Y Bellis; Srijita Banerjee; Aurore Morello; Vladimir Ponomarev; Jonathan Villena-Vargas; Prasad S Adusumilli
Journal:  Mol Ther Oncolytics       Date:  2021-06-12       Impact factor: 6.311
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.